Infosys, India’s second largest software services company, expects the recent spate of mergers and acquisitions (M&As) in the global pharmaceutical sector to boost its life sciences business over the next 12 months.
“There is a lot of M&A activity happening in the life sciences space. When M&A is typically initiated, budgets are tightly controlled, because companies are hoarding cash to ward off (rival bids) and to make the sale happen,” said Manish Tandon, senior vice-president and global segment head of life sciences.